Literature DB >> 16036308

Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells.

C Fernandez-Teruel1, I Gonzalez-Alvarez, V G Casabó, A Ruiz-Garcia, M Bermejo.   

Abstract

The absorption kinetics of sarafloxacin, as a model of fluoroquinolone structure, were studied in the rat small intestine and in Caco-2 cells. The objective of the study was to investigate the mechanistic basis of the drug's intestinal transport in comparison with other members of the fluoroquinolone family and to apply a mathematical modelling approach to the transport process. In the rat small intestine, sarafloxacin showed dual mechanisms of intestinal absorption with a passive diffusional component and an absorptive carrier-mediated component. The characteristics of the animal study design made it suitable for population analysis, thus allowing the accurate estimation of transport parameters and their inter and intra-individual variances. The transport system in the rat model was ATP-dependent, as sodium azide was able to decrease the absorption rate constant in a concentration-dependent fashion. The inhibition mechanism of sodium azide was modelled based on its ATP depletion capacity. The rationale of this approach was to consider the inhibitor-carrier interaction as a concentration- dependent response. This interaction was accurately described by a non-competitive mechanism. In Caco-2 cells, sarafloxacin showed a concentration dependent permeability in both directions apical to basal, and basal to apical. The permeability values and ratios of permeability values at different concentrations suggested the presence of two carriers (absorption and efflux carriers). The passive diffusion component in both systems was compared to that predicted by the absorption-partition correlation, previously established for two series of fluoroquinolones. The discrepancy between the experimental and predicted value suggested the presence of an efflux mechanism similar to that already described for other fluoroquinolones. The differences and similarities of the in situ and the in vitro results are discussed as well as the usefulness of the modelling approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036308     DOI: 10.1080/10611860500087835

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  6 in total

1.  Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters.

Authors:  J A Schrickx; J Fink-Gremmels
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

2.  Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.

Authors:  Isabel Lozoya-Agullo; Isabel Gonzalez-Alvarez; Moran Zur; Noa Fine-Shamir; Yael Cohen; Milica Markovic; Teresa M Garrigues; Arik Dahan; Marta Gonzalez-Alvarez; Matilde Merino-Sanjuán; Marival Bermejo; Alex Avdeef
Journal:  Pharm Res       Date:  2017-12-29       Impact factor: 4.200

3.  Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach.

Authors:  Hayet Bensikaddour; Nathalie Fa; Ingrid Burton; Magali Deleu; Laurence Lins; André Schanck; Robert Brasseur; Yves F Dufrêne; Erik Goormaghtigh; Marie-Paule Mingeot-Leclercq
Journal:  Biophys J       Date:  2008-01-04       Impact factor: 4.033

4.  Eremantholide C from aerial parts of Lychnophora trichocarpha, as drug candidate: fraction absorbed prediction in humans and BCS permeability class determination.

Authors:  Tamires Guedes Caldeira; Dênia Antunes Saúde-Guimarães; Isabel González-Álvarez; Marival Bermejo; Jacqueline de Souza
Journal:  Daru       Date:  2021-04-22       Impact factor: 3.117

5.  Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.

Authors:  Aaron M Moss; Christopher J Endres; Ana Ruiz-Garcia; Doo-Sup Choi; Jashvant D Unadkat
Journal:  Mol Pharm       Date:  2012-08-03       Impact factor: 5.364

6.  Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.

Authors:  Victor Mangas-Sanjuan; Jorge Gutiérrez-Nieto; Magdalena Echezarreta-López; Isabel González-Álvarez; Marta González-Álvarez; Vicente-Germán Casabó; Marival Bermejo; Mariana Landin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.